BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2693257)

  • 21. [CA130].
    Hogaki M
    Nihon Rinsho; 1999 Dec; 57 Suppl():466-9. PubMed ID: 10778166
    [No Abstract]   [Full Text] [Related]  

  • 22. [Biomarker in gynecologic malignancies].
    Isonishi S
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1003-7. PubMed ID: 15272576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical applications of ovarian cancer biomarkers].
    Kataoka F; Aoki D
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():543-8. PubMed ID: 23156306
    [No Abstract]   [Full Text] [Related]  

  • 24. Pathology of the ovary.
    McGowan L
    Curr Opin Obstet Gynecol; 1991 Aug; 3(4):580-6. PubMed ID: 1878514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor markers in epithelial ovarian cancer. Clinical applications.
    Hempling RE
    Obstet Gynecol Clin North Am; 1994 Mar; 21(1):41-61. PubMed ID: 8015766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serum CA125, CA19-9 and TPA in the diagnostic approach to neoplastic pathology of the ovary].
    Gadducci A; Bartolini T; Ferdeghini M; Facchini V; Bianchi R; Fioretti P
    Minerva Ginecol; 1987 Sep; 39(9):601-6. PubMed ID: 3479708
    [No Abstract]   [Full Text] [Related]  

  • 27. Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer.
    Scambia G; Panici PB; Baiocchi G; Perrone L; Iacobelli S; Mancuso S
    Anticancer Res; 1988; 8(4):761-4. PubMed ID: 3178164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor markers in ovarian carcinoma.
    Dudzinski MR
    Curr Opin Obstet Gynecol; 1990 Feb; 2(1):52-6. PubMed ID: 2102306
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sialyl Tn antigen].
    Kannagi R
    Nihon Rinsho; 1999 Dec; 57 Suppl():482-7. PubMed ID: 10778170
    [No Abstract]   [Full Text] [Related]  

  • 30. [STN (sialyl Tn antigen)].
    Kannagi R
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():698-702. PubMed ID: 20960853
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparison of the clinical usefulness of CA 19-9 and CA 50 in the diagnosis and monitoring of gastrointestinal cancers.
    Kokociñska D; Jarzab B; Król R; Ziaja K; Szejbak K; Kuśmierski S
    J Environ Pathol Toxicol Oncol; 1996; 15(2-4):283-7. PubMed ID: 9216823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative study of immunosuppressive acidic protein (IAP), CA 125 and acute-phase proteins as parameters for ovarian cancer monitoring.
    Koebl H; Tatra G; Bieglmayer C
    Neoplasma; 1988; 35(2):215-20. PubMed ID: 3259680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [CA-125: a serum tumor marker in ovarian cancer].
    Cohen AD; Piura B; Cohen Y
    Harefuah; 1994 Feb; 126(3):154-9. PubMed ID: 8168751
    [No Abstract]   [Full Text] [Related]  

  • 34. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.
    Hasholzner U; Baumgartner L; Stieber P; Meier W; Hofmann K; Fateh-Moghadam A
    Anticancer Res; 1994; 14(6B):2743-6. PubMed ID: 7532929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyst fluid CA 125 levels in ovarian epithelial neoplasms.
    Menczer J; Ben-Baruch G; Moran O; Lipitz S
    Obstet Gynecol; 1993 Jan; 81(1):25-8. PubMed ID: 8416456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis of the recurrence of epithelial ovarian cancer with the tumor marker CA 125].
    Sevelda P; Wagner G
    Wien Klin Wochenschr; 1987 Nov; 99(21):768-70. PubMed ID: 3480655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [CA-125 values in fluid and serum in females with cystic ovarian tumors].
    Sautter T; Mickan H
    Gynakol Rundsch; 1990; 30 Suppl 1():208-9. PubMed ID: 2079272
    [No Abstract]   [Full Text] [Related]  

  • 38. CASA and Ca 125 in diagnosis and follow-up of advanced ovarian cancer.
    Oehler MK; Sütterlin M; Caffier H
    Anticancer Res; 1999; 19(4A):2513-8. PubMed ID: 10470185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancer.
    Sliutz G; Tempfer C; Kainz C; Mustafa G; Gitsch G; Koelbl H; Biegelmayer C
    Anticancer Res; 1995; 15(3):1127-9. PubMed ID: 7645936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage colony-stimulating factor as a tumor marker for epithelial ovarian cancer.
    Suzuki M; Ohwada M; Aida I; Tamada T; Hanamura T; Nagatomo M
    Obstet Gynecol; 1993 Dec; 82(6):946-50. PubMed ID: 8233270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.